Pharmacology of antineoplastic agents in older cancer patients
- 19 February 2003
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 46 (2) , 101-114
- https://doi.org/10.1016/s1040-8428(02)00120-8
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Carboplatin dosing formulae: gender bias and the use of creatinine-based methodologiesEuropean Journal Of Cancer, 2002
- Carboplatin dosingEuropean Journal Of Cancer, 2002
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- Pharmacokinetics and tolerance of vinorelbine in elderly patients with metastatic breast cancerEuropean Journal Of Cancer, 1997
- The charing cross hospital experience with temozolomide in patients with gliomasEuropean Journal Of Cancer, 1996
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumoursEuropean Journal Of Cancer, 1993
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Variable Bioavailability of Oral MercaptopurineNew England Journal of Medicine, 1983
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976